Monday 20 May 2024 (5th Week, Trinity Term)

• 12:00 - CAR T-cell immunotherapy of solid tumours: moving through the generations
  In-person only
  Dr John Maher (King's College London)
  Kennedy Institute Seminars

Tuesday 21 May 2024 (5th Week, Trinity Term)

• 12:00 - Developing a viable MYC inhibitor for cancer treatment: a challenging journey from the lab to the clinic
  Join us in person or via Teams - e-mail carolyn.thackrah@pharm.ox.ac.uk
  Dr Laura Soucek (CEO and PI, Peptomyc)
  Pharmacology, Anatomical Neuropharmacology and Drug Discovery Seminars

Wednesday 22 May 2024 (5th Week, Trinity Term)

• 13:30 - Retroviral legacy in immunity and cancer
  In person only
  Professor George Kassiotis (The Francis Crick Institute, London)
  MRC TIDU Wednesday Seminar Series

Friday 24 May 2024 (5th Week, Trinity Term)

• 13:00 - Targeting the Epigenetic Machinery to Modulate Anti-tumor Immunity
  In person only
  Professor Sangeeta Goswami (University of Texas MD Anderson Cancer Center, Houston, Texas)
  CIO Seminar Series

Thursday 30 May 2024 (6th Week, Trinity Term)

• 11:00 - Targeting TCR and Co-Receptor Signaling in T Cell-Mediated Immunity
  this is a hybrid event - please email marie-laure.foisneau-bates@ludwig.ox.ac.uk for zoom details
  Dr Ricardo Fernandes (CAMS Oxford Institute, University of Oxford)
  Ludwig Institute Seminar Series

Friday 7 June 2024 (7th Week, Trinity Term)

• 08:30 - Oxford Cancer Immuno-Oncology Network 2024 Annual Symposium
  Various Speakers
  Oxford Cancer Centre for Immuno-Oncology

Thursday 4 July 2024 (11th Week, Trinity Term)

• 13:00 - Comprehensive therapeutic targeting of the oncogene driver MYCN in childhood cancer
  Prof Louis Chesler (The Institute of Cancer Research), Professor John Anderson (University College London)